SCHEMBL7664530

SCHEMBL7664530

CN(C)S(=O)(=O)n1c(Cc2ccccc2)cnc1[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GLA P06280 1/20 0.32
KDM4E B2RXH2 2/20 0.32
IDH1 O75874 1/20 0.32
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4056925 0.88 ALDH1A1 (0.33) TSHRALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7705910 0.82 CA2 (0.32) TSHR
SCHEMBL7622153 0.81 SORD (0.32)
SCHEMBL4384751 0.79 SORD (0.30)
SCHEMBL4388950 0.78
SCHEMBL4376123 0.77
SCHEMBL7194100 0.77
SCHEMBL4386625 0.77
SCHEMBL4380984 0.77
SCHEMBL6427238 0.76 TSHR (0.35) TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407132-B1 ANTIHISTAMINES, ANTIALLERGENS, ANTIASTHMATICS, ANTICONVULSANTS, AND ANTIDEPRESSANTS; SKIN RASH TREATMENT JAMES BLACK FOUNDATION LIMITED (GB) 2002-06-18 US disclosed